More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$574760200
P/E ratio
23.1
Dividend yield
0.8764%
Expense ratio
0.58%
Beta
0.433852
Previous close
$129.86
Today's open
$128.86
Day's range
$128.42 - $129.44
52 week range
$99.05 - $132.59
Industries
Health
PJP: Healthcare Sector Dashboard For November
The healthcare equipment industry is undervalued based on historical averages, while pharma/biotechnology is significantly overvalued. Invesco Pharmaceuticals ETF (PJP) offers multi-factor pharmaceutical exposure suited to long-term and tactical allocations. PJP outperformed the sector benchmark XLV since inception and over the past 12 months, but lagged it from July 2015 to July 2025.
Seeking Alpha • Nov 17, 2026

Better Healthcare ETF: Invesco's PJP vs. Simplify's PINK
The Invesco Pharmaceuticals ETF has delivered significantly higher 1-year total returns than the Simplify Health Care ETF. The Simplify Health Care ETF operates with a lower expense ratio and follows a unique pro bono model that supports breast cancer research.
The Motley Fool • Nov 16, 2026

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
iShares Global Healthcare ETF features a lower expense ratio and a higher dividend yield than Invesco Pharmaceuticals ETF. Invesco Pharmaceuticals ETF provides concentrated exposure to 28 U.S. drugmakers, whereas iShares Global Healthcare ETF holds 109 global positions.
The Motley Fool • Nov 7, 2026

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the Invesco Pharmaceuticals ETF (PJP), a passively managed exchange traded fund launched on June 23, 2005.
Zacks Investment Research • Nov 3, 2026

How to Invest in the Rise of China's Biotech: Buy U.S. Drug Stocks
Many of the hot new drug candidates in the U.S. were developed Chinese companies.
Barrons • Nov 3, 2026

Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lens
The Invesco S&P 500 Equal Weight Health Care ETF offers a lower expense ratio and broader diversification than the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has generated higher 1-year and 5-year total returns while maintaining lower price volatility.
The Motley Fool • Oct 11, 2026

Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
The VanEck Pharmaceutical ETF offers a lower expense ratio of 0.36% compared to 0.58% for the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF has delivered a higher 1-year total return of 41% relative to 31% for the VanEck fund.
The Motley Fool • Oct 3, 2026

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
The Invesco Pharmaceuticals ETF (PJP) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Zacks Investment Research • Sep 28, 2026

XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks
The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly lower ownership costs, with an expense ratio of 0.08% compared to 0.58% for the Invesco Pharmaceuticals ETF (PJP). PJP provides concentrated exposure to 28 pharmaceutical stocks, while XLV holds 61 diversified healthcare companies.
The Motley Fool • Sep 23, 2026

FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Fidelity MSCI Health Care Index ETF (FHLC) offers a significantly lower expense ratio and a higher dividend yield than the Invesco Pharmaceuticals ETF (PJP). PJP provides a concentrated portfolio of just over 30 pharmaceutical stocks, while FHLC diversifies across more than 300 holdings.
The Motley Fool • Aug 23, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Invesco Dynamic Pharmaceuticals ETF commission-free¹. Build wealth for the long term using automated trading and transfers.